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Abstract  
 
Purpose: A newly developed high-penetration Doppler optical coherence angiography (HP-OCA) with a 
1-μm probe beam for non-invasive investigation of vascular pathology of exudative macular diseases is 
introduced. A descriptive case series is presented to discuss the clinical utility of HP-OCA.  
Methods: Eleven eyes of 10 subjects with exudative macular disease, including 2 eyes with myopic 
choroidal neovascularization (mCNV), 4 eyes with age-related macular degeneration (AMD) and 5 eyes 
with polypoidal choroidal vasculopathy (PCV), were investigated. Two Doppler scanning modes 
(bi-directional and high-sensitive) of HP-OCA were used for the investigation. HP-OCA provides depth 
resolved and en face angiograms and a structural OCT noninvasively. The HP-OCA images were 
compared with fluorescein angiography (FA), indocyanine green angiography (ICGA) and color fundus 
images. 
Results: The abnormal vasculature patterns observed with high-sensitive HP-OCA presented high 
similarity to the mid-phase of ICGA. Several abnormal Doppler signals were observed in the en face 
high-sensitive HP-OCA and were co-located with FA leakage. This co-location was found in 1 eye with 
mCNV, 4 eyes with AMD, and 1 eye with PCV. Doppler tomogram of the bi-directional mode showed 
abnormal Doppler signals in 3 of 5 PCV cases beneath the pigment epithelium detachment. With the 
high-sensitive mode, Doppler signals were found beneath the elevated retinal pigment epithelium in all 
untreated cases. 
Conclusions: HP-OCA revealed depth-resolved abnormal vasculatures in exudative macular diseases. 
The en face HP-OCA images showed high similarity with FA and ICGA images. These results suggest 
HP-OCA can be used for non-invasive and three-dimensional angiography in a clinical routine. 
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Exudative macular diseases threaten vision ability of humans. Among them, pathological myopia and 
age-related macular degeneration (AMD) are representative causes of blindness worldwide1–5. These 
diseases frequently appear with choroidal neovascularization (CNV).  Polypoidal choroidal vasculopathy 
(PCV) is one form of CNV and it is characterized by a branching vascular network (BVN) terminating in 
polypoidal lesions6,7. In Asian countries, PCV represents between 56% and 72% of all neovascular AMD 
patients1. 
One of the most effective treatments of CNV is intravitreal injection of bevacizumab or 
ranibizumab. This treatment requires repeated injection with several rounds with 1- to 3-month periods, 
and fluorescence angiography (FA) and indocyanine green angiography (ICGA) images are required for 
the initial diagnosis. However, FA and ICGA imaging is sometimes restricted, because they are invasive 
methods requiring dye injection into a vein, which makes patients uncomfortable, and sometimes induces 
adverse reactions8,9. Hence, it is clinically important to establish a new modality that non-invasively 
reveals the vasculature including abnormal vasculature. 
Optical coherence tomography (OCT) has been an innovative ophthalmic diagnostic modality that 
provides non-invasive optical biopsy imaging10.  However, conventional OCT with an 840 nm probe 
beam can visualize only limited structures beneath the RPE. It is known that light with a wavelength of 
around 1050 nm is less scattered in the choroid and less absorbed in the RPE, and OCT with a 1050 nm 
probe beam, also referred to as high-penetration OCT (HP-OCT), has been demonstrated for 
high-penetration imaging of the posterior eye11. Visualization of sub-RPE morphologies in exudative 
macular disease by HP-OCT has also been demonstrated12,13. 
In addition to structural imaging, Doppler OCT, a functional extension of OCT, has been 
demonstrated to image flow in living tissues14–20. Doppler OCT provides depth-resolved flow contrast by 
detecting the Doppler shift of a probe beam induced by the motion of scatterers in the sample. This 
technique and its variations are utilized both for quantitative flow investigation21–24 and detailed structural 
investigation of the vasculature25–29. The former is now possible with a commercially available OCT 
device, such as the RTView (Optovue Inc. CA). The latter, so called OCT angiography or optical 
coherence angiography (OCA), is still in a research stage, but has been successfully applied in the 
investigation of exudative macular diseases29. 
Recently, the OCA method has been combined with an HP-OCT engine30–32. This high-penetration 
optical coherence angiography (HP-OCA) enables vascular imaging of the deep posterior eye. 
The purpose of this paper is evaluating the clinical utility of HP-OCA as a non-invasive 
angiographic modality. We introduce a custom built HP-OCA32 to investigate the vascular pathology of 
exudative macular diseases. A descriptive case series of myopic CNV (mCNV), AMD and PCV are 
presented. Through detailed discussion of the cases, the clinical utility of HP-OCA is also discussed.  
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Subjects and Method 
Eleven eyes of 10 subjects were involved in this study as summaries in Table 1s. The subjects included 2 
eyes of 2 subjects with mCNV, 4 eyes of 4 subjects with AMD, and 5 eyes of 4 subjects with PCV. All 
subjects were Japanese. The mean age of the patients was 61.3 ± 14.2 (mean ± standard deviation), and the 
age ranged from 32.8 to 82.3. Specifically, the mean age of the subjects with each type of disease was 38.8 
± 8.5 for mCNV, 61.9 ± 5.8 for AMD and 72.0 ± 7.5 for PCV. The mean of the spherical equivalent 
refractive error of the eyes was -2.3 ± 3.8 D ranging from -11 D to 1.5 D. Specifically, the mean refractive 
error of the eye for each type of disease was -8.3 ± 3.9 D for mCNV, 0.1 ± 0.6 D for AMD, and -1.9 ± 2.9 
D for PCV.  
 
 
Table 1. Summary of subjects  
Patient ID Eye Sex Age Diopter Diagnosis # of IVR 
Subject-1 R M 44.9 -11.0 mCNV 3 
Subject-2 L M 32.8 -5.5 mCNV 0 and 2 
Subject-3 L F 68.5 1.0 AMD (Classic) 0 and 3 
Subject-4 L M 61.5 0.0 AMD (Classic) 0 and 5 
Subject-5 L M 63.1 0.0 AMD (Classic) 0 
Subject-6 L M 54.4 -0.5 AMD (Classic) 0 and 3 
Subject-7 L M 82.3 -0.5 PCV 0 
Subject-8 
R  
M 71.8 
-5.0 PCV 0 
L -5.0 PCV 0 
Subject-9 R M 68.8 1.5 PCV 0 
Subject-10 L M 64.9 -0.5 PCV 0 
R: right, L: left, M: male, F: female, # of IVR: number of intravitreal injection of 
ranibizumab prior to the investigation with HP-OCA. The multiple numbers in the cell of [# 
of IVR] represent multiple measurements by HP-OCA after the each number of treatments. 
 
 
The patients were diagnosed at Ibaraki Medical Center Hospital, Tokyo Medical University. All 
subjects received a comprehensive ophthalmic examination including color fundus photography, spectral 
domain OCT with an 830-nm probe (3D OCT-2000, Topcon Corp., Tokyo, Japan), FA, and ICGA. 
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Subjects who showed an allergic reaction to fluorescein, one of mCNV and one of PCV, did not receive 
FA. 
Patients who were diagnosed as exudative macular disease were transferred to an optics laboratory 
at the University of Tsukuba, where their eyes were scanned with a custom built HP-OCA.  
The research protocol adhered to the tenets of the Declaration of Helsinki and was approved by the 
institutional review board of Tokyo Medical University and the University of Tsukuba. Informed consent 
was obtained from the subjects after providing an explanation of the nature and possible consequences of 
the research. 
  
High-penetration Doppler optical coherence angiography 
The HP-OCA device is a prototype built by the Computational Optics Group at the University of 
Tsukuba. This OCA is based on swept-source OCT technology and offers a measurement speed of 
100,000 A-lines/s. With a single scan of the eye, HP-OCA provides both high-penetration OCT and 
Doppler tomograms. The Doppler tomography signal is obtained by the phase difference between two 
OCT A-lines, and reflects the Doppler shift of the probe beam. Doppler shift is induced by the flowing 
red blood cells in the vessels. Based on this mechanism, the Doppler tomography selectively visualizes 
the ocular vasculature. 
This device has two measurement modes for two types of Doppler tomography. The first mode is a 
bi-directional mode, which calculates the Doppler signal from two successive A-lines. This mode is 
sensitive to relatively fast flow; in our particular configuration it was from 1.75 mm/s to 19.2 mm/s (axial 
velocity) and it provides bi-directional axial flow velocity. A potential drawback of this mode is the 
relatively high minimum measurable velocity (1.75 mm/s). A flow signal slower than this limit is not 
detectable. In this paper, the bi-directional cross-sectional tomogram, in which the bi-directional Doppler 
signal overlaid on structural OCT, is denoted as bi-directional Doppler tomogram, while en face 
projection of the squared bi-directional Doppler tomogram is denoted as bi-directional OCA. 
The second mode is the high-sensitive mode, in which the Doppler signal is calculated from two 
A-lines in two successive B-scans. This mode is sensitive to relatively slow flow, such as > 5.2 μm/s 
(axial velocity) in our particular configuration. A potential drawback of this mode is relatively low 
maximum measureable velocity (60 μm/s) for quantitative measurement. A flow signal faster than this 
limit is wrapped into the measureable Doppler range and appears as a strong but random pattern. Hence 
this high-sensitive mode is not suitable for qualitative bi-directional measurement, but suitable for 
high-contrast selective imaging of small vessels. In this mode, the image is displayed in the form of the 
squared energy of the Doppler signal, and is utilized for small vascular observation with flow-selective 
contrast. In this paper, a high-sensitive Doppler signal overlaid on structural cross-sectional OCT is 
denoted as high-sensitive Doppler tomogram, and the en face projection of the high-sensitive Doppler 
signal is denoted as high-sensitive OCA. 
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The details of this HP-OCA are described elsewhere32, except for a new signal processing method 
for eye motion correction. The details of this modification are presented in the supplementary section (S1). 
It should be noted that the bi-directional mode and high-sensitive mode are denoted as the fast Doppler 
mode and slow Doppler mode, respectively, in Ref. 32. 
The HP-OCA scans the 6 mm × 6 mm area around the pathologic region with 2048 A-lines 
(horizontal) × 256 B-scans (vertical) for bi-directional mode and 256 A-lines (horizontal) × 2048 B-scans 
(vertical) in the high-sensitive mode. Each measurement took 6.6 seconds. It should be noted that a 
finally obtained en face OCA image of high-sensitive mode is not always perfectly rectangle. This is 
because of invalid A-lines caused by high-frequency scanning of a scanning mirror in the OCT scanner 
and its resulting synchronization imperfection between the scanning mirror and data acquisition. 
Figure 1 shows typical images of en face OCA (Figure 1e and Figure 1f), OCA tomogram (Figure 
1g and Figure 1h) and corresponding color fundus (Figure 1a) and ICGA (Figure 1b and Figure 1c) 
images, which were obtained from a normal macula of a 37-year-old Japanese male with -6.0 D myopia. 
The en face OCT projection image (Figure 1d) was obtained by the depth average of the logarithmic OCT. 
Thick choroidal vessels were observed with moderate hyposcattering in the OCT en face projection 
(Figure 1d); however, the visualization of choroidal vessels were limited compared to the mid-phase of 
ICGA (Figure 1c). Bi-directional OCA (Figure 1e) and high-sensitive OCA (Figure 1f) showed different 
vasculatures. The retinal vasculature of the macular region was rarely imaged with bi-directional OCA, 
while high-sensitive OCA visualized similar retinal vasculature to that of color fundus photograph and the 
mid-phase of ICGA. For imaging of the choroidal vasculature, the bi-directional OCA showed mainly 
thick choroidal vasculatures that had fast axial blood flow and appeared in the early-phase of ICGA 
(Figure 1b), while high-sensitive OCA showed a similar choroidal vasculature to that of the mid-phase of 
ICGA. In addition, several choroidal vessels that did not appear in the mid-phase ICGA were also 
visualized in the high-sensitive OCA.  
The depth locations of the blood flow are identifiable in Doppler tomogram. In bi-directional 
Doppler tomogram (Figure 1g), red and blue color represent axial flow directions to the anterior or to the 
posterior, respectively, and the locations of the flow are indicated with arrows. Figure 1h is a vertical 
high-sensitive Doppler tomogram. The weaving appearance in this Doppler tomogram was caused by 
imperfect axial motion correction among the horizontal frames. 
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Figure 1. Macular images of a normal eye with -6.0 D myopia of a 37-year-old Japanese 
male. (a) is a color fundus photograph, (b) and (c) are early-phase and mid-phase ICGA 
images, respectively, and (d) is an en face projection of structural OCT. (e) and (f) are 
bi-directional and high-sensitive OCAs, respectively. (g) and (h) are bi-directional and 
high-sensitive Doppler tomogram, respectively. Scale bars in (d) and (g) indicate 0.5 mm. 
   
Results 
Case-1: Myopic CNV  
Figure 2 shows a case of mCNV. The subject was a 45-year-old man who had been received intravitreal 
ranibizumab injection three times prior to the HP-OCA examination. Figure 2a, Figure 2b and Figure 2c 
represent the color fundus, FA (late-phase) and ICGA (mid-phase) images, respectively, corresponding to 
the area of the HP-OCA examination. 
RPE elevation was observed in structural OCT (Figure 2f), which was simultaneously obtained 
with bi-directional tomogram as well as in the high-sensitive Doppler tomogram as indicated by yellow 
arrows (Figure 2g). In high-sensitive Doppler tomogram, abnormal Doppler signals were observed in the 
sub-RPE space beneath the elevated RPE and above Bruch’s membrane as indicated by a red arrow.  
The region of RPE elevation appeared with hyperscattering in en face structural OCT (Figure 2d) and 
with hyper-Doppler signals in high-sensitive OCA as indicated by arrows (Figure 2e). These signals were 
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co-located with the hyperreflective spot in the color fundus (an arrow in Figure 2a) and the 
hyperfluorescence signal in FA (an arrow in Figure 2b), which is the indicator of inactive CNV. The 
hyperscattering in the structural OCT projection was surrounded by a hyposcattering rim, as a similar 
appearance was shown in the color fundus. Similarly, the hyper-Doppler spot in the en face OCA was 
surrounded by a hypo-Doppler rim, which was similar to a pattern that appeared in the ICGA image (an 
arrow in Figure 2c). The pattern of CNV appearance in the en face structural OCT and OCA was found in 
2 of 2 cases with mCNV, 4 of 4 cases with AMD, and 1 of 4 cases with PCV. It is also noteworthy that 
high-sensitive OCA showed a high overall similarity to the mid-phase of ICGA. 
 
 
 
Figure 2. Right macular images of a 45-year-old man with mCNV, (a) color fundus, (b) FA 
(late-phase), (c) ICGA (mid-phase), en face projections of (d) structural OCT and (e) 
high-sensitive OCA, (f) structural OCT taken by a scanning protocol of bi-directional mode 
and (g) high-sensitive Doppler tomogram. Yellow dashed line in (d) and (e) indicate the 
location of tomograms of (f) and (g), respectively. Scale bars in (d) and (f) indicate 0.5 mm. 
A fly-through movie of (g) is available as supplementary of S2. 
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Case-2: Myopic CNV with ranibizumab injection 
Figure 3 summarizes another case with mCNV. The subject was a 33-year-old man who was treated with 
intravitreal ranibizumab injection (0.05 ml of 10 mg/ml solution for each injection) two times with a 
28-day separation. HP-OCA examination was performed 6 days before the first injection and 59 days 
after the second injection. 
Figure 3a, Figure 3b and Figure 3c are mid-phase ICGA, high-sensitive OCA, and en face 
structural OCT projection taken before the treatment, respectively. Figure 3d, Figure 3e and Figure 3f are 
corresponding images taken after the injection. The CNV was observed as a hyperfluorescent region 
surrounded by a dark rim in the ICGA image (red arrow in Figure 3a) before the treatment. This CNV 
area became smaller after the ranibizumab injection (red arrow in Figure 3d). This CNV appeared as a 
hyper-Doppler region surrounded by a dark rim in the OCA image (red arrow in Figure 3b), and it also 
became smaller after the ranibizumab injection (red arrow in Figure 3e). This appearance was well 
correlated with ICGA. This CNV region appeared as a large hyper-scattering region in en face OCT (a 
circle in Figure 3c), and this region became smaller after the injection (a circle in Figure 3f). 
Figure 3g and Figure 3h are vertical high-sensitive Doppler tomograhies. These tomograhies 
were created from the same datasets of Figure 3b and Figure 3c, and Figure 3e and Figure 3f, respectively, 
and the locations of the tomograms are indicated by dashed lines in the en face images. Note that the 
vertical gap in Figure 3g was created by an eye blink. Before the ranibizumab injection, subretinal fluid 
(blue arrow) and exudates (yellow arrow) were evident in the structural OCT (Figure 3g). The RPE in the 
exudative region was hardly visible. In addition to structural tomogram, Doppler tomogram provided 
more detailed insight. Hyper-Doppler signals were observed in the exudates and the choroid beneath the 
exudates (a red arrow in Figure 3g), which indicated abnormal flow in this region. After ranibizumab 
injection, as shown in Figure 3h, sub-retinal fluid disappeared and the CNV related elevation became 
smaller. The RPE became clearly visible with structural OCT. With Doppler tomogram, it was found that 
the abnormal blood flow disappeared (Figure 3h). 
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Figure 3. Left macular images of a 33-year-old man with mCNV taken before and after the 
ranibizumab treatment. (a) and (d) ICGAs (mid-phase), (b) and (e) high-sensitive OCAs, (c) 
and (f) en face structural OCT projections taken with the high-sensitive scanning mode, and 
(g) and (i) high-sensitive Doppler tomograms. (a)-(c) and (g) were taken before treatment 
and (d)-(f) and (i) were taken after treatment. Scale bars in (c) and (g) indicate 0.5 mm. 
Fly-through movies of (g) and (h) are available as supplementaries of S3 and S4. 
 
Case-3: AMD 
Figure 4 summarizes a case of AMD with classic CNV. The subject was a 62-year-old man. An active 
CNV was observed at the fovea by dye leakage in the late-phase of FA (arrow in Figure 4b). The 
mid-phase of ICGA (Figure 4c) shows CNV that appeared as hyperfluorescence surrounded by a dark rim 
(arrow). Several hard drusen were observed in the color fundus as white spots (Figure 4a). 
OCT en face projection (Figure 4d) shows a similar appearance to the color fundus photograph 
including hyperscattering spots and choroidal vasculatures. It is noteworthy that the choroidal vasculature 
around the CNV appeared with hyperscattering signal (red arrow inside a circle), while other choroidal 
vessels in non-pathologic regions generally appeared with hyposcattering, as indicated by a yellow arrow. 
This appearance would be caused by the deeper penetration beneath the choroidal vessels around the CNV, 
as indicated by red arcs in the horizontal structural OCT cross-section taken with the bi-directional 
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scanning protocol (Figure 4f). 
High-sensitive OCA (Figure 4e) showed almost all of the retinal and choroidal vessels shown 
in the mid-phase of ICGA ((Figure 4c) even with higher contrast. Remarkably, the detailed abnormal 
choroidal vasculature was observed at the CNV region, as indicated by a circle in Figure 4e, while it was 
hardly observed in ICGA. 
In high-sensitive Doppler tomogram (Figure 4g), RPE elevation was observed. Remarkably, 
abnormal Doppler signals were observed beneath the elevated RPE, as indicated by an arrow.  
 
 
 
Figure 4. Left macular images of a 62-year-old man with AMD, (a) color fundus, (b) FA 
(late-phase), (c) ICGA (mid-phase), (d) en face projection of structural OCT, (e) 
high-sensitive OCA, (f) structural OCT cross-section taken with bi-directional scanning 
mode, and (g) high-sensitive Doppler tomogram. Yellow dashed lines in (d) and (e) indicate 
the locations of (f) and (g), respectively. Scale bars in (d) and (f) indicate 0.5 mm. A 
fly-through movie of (g) is available as supplementary of S5. 
 
Case-4: AMD with ranibizumab injection 
Figure 5 summarizes another case of AMD with classic CNV. The subject was a 69-year-old woman 
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treated with intravitreal ranibizumab injection 3 times within time periods of 28 days and 35 days. The 
first HP-OCA examination was performed 4 days before the first injection and the second examination 
was done 49 days after the third injection. 
 Figure 5a‒Figure 5d represent late-phase FA, mid-phase ICGA, high-sensitive OCA, and 
structural OCT projection, respectively, taken before the first injection. Figure 5e‒Figure 5h are 
corresponding images taken after the third injection. The active CNV, indicated by a red arrow in the FA 
image (Figure 5a) became inactive after three injections, as shown in Figure 5e. In the ICGA images, the 
CNV appeared as hyperfluorescence surrounded by a dark rim, as indicated by arrows in Figure 5b and 
Figure 5f. The size of the CNV region was reduced by the injections. A similar appearance with ICGA 
was found in high-sensitive OCA images, as indicated by arrows in Figure 5c and Figure 5g, where a 
hyper-Doppler signal was surrounded by a hypo-Doppler rim. The size of this appearance was also 
reduced by the ranibizumab injections. 
In en face OCT projection (Figure 5d), active CNV appeared with hyperscattering (red arrow). 
This hyperscattering decreased after the ranibizumab injection (red arrow in Figure 5d). In the 
post-injection OCT image, some other hyper-scattering spots were observed (yellow arrows in Figure 5h). 
These hyperscattering spots were well correlated with the hyperfluorescence of FA (arrows in Figure 5e). 
A clear difference was observed between the OCT cross-sections taken before and after the 
injections. Before the treatment (Figure 5i), exudates were observed as indicated by a yellow arrow. In 
this region, the RPE was not clearly observed. In the corresponding high-sensitive Doppler tomogram, 
hyper-Doppler signals were observed in the exudates as indicated by a red arrow in Figure 5j. After the 
injections, exudates disappeared and only a small RPE elevation was observed (yellow arrow in Figure 
5k). In high-sensitive Doppler tomogram (Figure 5l), nearly no abnormal Doppler signal was observed 
(arrow). 
13 
 
 
Figure 5. Left macular images of a 69-year-old woman with AMD taken before and after 
the three times of intravitreal ranibizumab injection. (a) FA (late-phase), (b) ICGA 
(mid-phase), (c) high-sensitive OCA, and (d) en face structural OCT projection images 
taken using the high-sensitive scanning mode before the first ranibizumab injection. (e)–(h) 
are corresponding images taken after the third ranibizumab injection. (i) and (j) are 
structural OCT and high-sensitive Doppler tomogram taken before the first injection. The 
locations of these tomograms are indicated by yellow lines in (c) and (d). (k) and (l) are 
those taken after the third injection. The yellow lines in (g) and (h) indicate the location of 
these tomograms. Scale bars in (d) and (i) indicate 0.5 mm. Fly-through movies of (j) and 
(l) are available as supplementaries of S6 and S7. 
 
Case-5: PCV 
Figure 6 summarizes a case of PCV that appeared with a large abnormal vascular network. The subject 
was a 65-year-old man and his left eye was examined. The eye was not treated at the time of the 
examination. Widely spread exudates were observed with white color in the fundus photograph (Figure 
6a). The hyperfluorescent region in the late-phase FA (Figure 6g) indicated a large pigment epithelial 
detachment (PED). Abnormal vasculature and polypoids were observed in the mid-phase of ICGA (Figure 
6c). In en face OCT projection (Figure 6d), a strong hyperscattering (left circle) and a moderate 
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hyper-scattering (right circle) were observed. This corresponded to the hyperfluorescence regions in FA 
(Figure 6g). 
In bidirectional Doppler tomogram (Figure 6h), clear Doppler signals were observed beneath 
the moderate PED (red arrow). Figure 6e shows the bi-directional OCA, where the red arrow indicates the 
Doppler signal in Figure 6h. When comparing this OCA and early phase ICGA (Figure 6b), it is evident 
that this Doppler signal corresponds to a feeder vessel. 
In high-sensitive Doppler tomogram (Figure 6i), many abnormal Doppler signals were 
observed beneath the PED as indicated by the red arrows. Remarkably, some Doppler signals, such as that 
indicated by the leftmost arrow, represented abnormal vessels that penetrated Bruch’s membrane into the 
sub-RPE space. The high-sensitive OCA (Figure 6f) shows a highly correlated pattern with the mid-phase 
of ICGA (Figure 6c).     
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Figure 6. Left macular images of a 65-year-old man with PCV with a large area of polypoid, 
(a) color fundus photograph, (b) early-phase of ICGA, (c) mid-phase of ICGA, (d) en face 
projections of structural OCT, (e) bi-directional OCA, (f) high-sensitive OCA, (g) 
late-phase of FA, (h) bi-directional Doppler tomogram, and (i) high-sensitive Doppler 
tomogram. Yellow dashed lines in (e) and (f) indicate the location of (h) and (i), 
respectively. Scale bars in (d) and (h) indicate 0.5 mm. Fly-through movies of (h) and (i) 
are available as supplementaries of S8 and S9. 
 
Case-6: PCV 
Figure 7 summarizes another case of PCV. The subject was a 69-year-old man. The early-phase of ICGA 
(Figure 7a) shows a clear branching vascular network (BVN) at the PED area. The late-phase of ICGA 
(Figure 7d) shows terminal aneurismal dilatation of the BVN. High-sensitive OCA (Figure 7b) shows a 
highly correlated vascular pattern including the BVN with the early-phase of ICGA. High-sensitive 
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Doppler tomogram (Figure 7g) presents several Doppler signals beneath the PED (arrows). The location 
of this Doppler tomogram is indicated on ICGAs (Figure 7a and Figure 7d) and en face OCA (Figure 7b) 
with yellow lines. This indicates that the Doppler signals beneath the PED in Figure 7g are associated 
with the BVN. 
A volume rendering of the high-sensitive OCA provides more intuitive understanding, as 
shown in Figure 7e, where the Doppler signal and the structural OCT signal are respectively displayed in 
orange and green colors. In this image, the comprehensive three-dimensional structure of the BVN is 
clearly visualized. In addition, a blood vessel connecting the BVN to the choroid is clearly observed as 
indicated with an arrow.    
An active CNV is observed in FA, as indicated by a circle in Figure 7c. A similar pattern is 
observed in high-sensitive OCA (Figure 7b) and OCT en face projection (Figure 7f) with hyper-Doppler 
and hyperscattering, respectively. Corresponding Doppler signals are observed in the choroid under the 
PED (arrow in Figure 7h).  
 
Figure 7. Right macular images of a 69-year-old man with PCV with a clear BVN. (a) 
early-phase and (d) late-phase ICGA, (b) high-sensitive OCA, (e) volume rendering of 
high-sensitive three-dimensional Doppler tomogram, (c) late-phase FA, (f) en face 
projection of structural OCT. (g) and (h) are high-sensitive Doppler tomograms. The 
location of (g) is indicated by dashed lines in (a), (b), and (d), while the location of (h) is 
indicated by yellow lines in (b), (c), and (f). Scale bars in (f) and (g) indicate 0.5 mm. A 
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volume rendering movie of (e) and a combined fly-through movie of (g) and (h) are 
available as supplementaries of S10 and S11. 
 
Visibility of Doppler signals at abnormal choroidal vessels 
Two graders (YJH and MM) graded the visibility of abnormal Doppler signals. A fly-through sequence of 
structural OCT, Doppler tomogram, and the Doppler tomogram overlaid on the structural OCT were 
presented to the graders. In this grading, the eyes with Doppler signals at abnormal regions found in 
structural OCT were labeled as positive and the other eyes were labeled as negative. This grading was 
independently done for the following three regions; (1) an abnormal region anterior to the RPE, (2) a 
region between the RPE and Bruch’s membrane, and (3) within Bruch’s membrane, i.e., Doppler signal 
penetrated through Bruch’s membrane.  
 
 
Table 2 summarizes the occurrence of Doppler signals at abnormal choroidal vessels graded by 
two graders and their agreements. In this table, the three regions described above were denoted as “above 
RPE,” “RPE-Bruch,” and “in Bruch.” The three numbers in each cell represent, from the left, the number 
of positive eyes found by grader YJH, that found by grader MM, and the number of eyes in which the 
grading of the two graders are agreed.   
With bi-directional Doppler tomogram, abnormal flows were observed in PCV eyes with 80% 
by grader YJH and 60% by MM. Conversely, no abnormal flow was observed in mCNV and AMD cases. 
High-sensitive OCA showed a high occurrence of abnormal Doppler signals within the untreated eyes 
with both graders. The grading of the two graders were perfectly agreed except the following three cells; 
the bi-directional Doppler of untreated PCV at the “RPE-Bruch” and “in Bruch” region, high-sensitive 
Doppler of untreated PCV at the “In Bruch” region, and high-sensitive Doppler of mCNV at the 
“RPE-Bruch” region. And hence, the overall agreement of all cells in  
Table 2 was 89% (82/90).  
 
Table 2. Visibility of Doppler signal at abnormal choroidal vessels graded by two graders and their 
agreement 
Doppler 
mode 
Region 
Untreated Treated 
mCNV 
(N=1) 
AMD 
(N=4) 
PCV  
(N=5) 
mCNV 
(N=2) 
AMD 
(N=3) 
Bi- 
directional 
mode 
Above RPE 0, 0, 1 0, 0, 4 0, 0, 5 0, 0, 2 0, 0, 3 
RPE-Bruch 0, 0, 1 0, 0, 4 4, 3, 4 0, 0, 2 0, 0, 3 
In Bruch 0, 0, 1 0, 0, 4 2, 1, 2 0, 0, 2 0, 0, 3 
High- Above RPE 1, 1, 1 3, 3, 4 0, 0, 5 0, 0, 2 0, 0, 3 
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sensitive 
mode 
RPE-Bruch 0, 0, 1 1, 1, 4 5, 5, 5 1, 2, 1 1, 2, 3 
In Bruch 1, 1, 1 4, 4, 4 4, 5, 4 1, 1, 2 1, 2, 3 
A summary occurrence of Doppler signals in bi-directional and high-sensitive Doppler 
tomograms. The values in each cell, from the left, represent the number of eyes in which 
the Doppler signal was found by grader YJH, that found by MM, and agreement between 
two graders. N is the number of eyes. Three regions are defined as: (1) an abnormal region 
anterior to the RPE (above the RPE), (2) a region between the RPE and Bruch’s membrane 
(RPE-Bruch), and (3) within Bruch’s membrane (in Bruch), in which case a Doppler signal 
penetrated through Bruch’s membrane   
 
Discussion 
In the en face OCT projections of 1 eye with AMD (Figure 4d) and 2 eyes of a single case of PCV, the 
choroidal vessels appeared with hyperscattering at the pathologic regions, while it appeared with 
hyposcattering in non-pathologic regions. It is also known that, the choroidal vessels appeared with 
hyposcattering in the en face OCT projection of normal eyes. In these pathologic regions, abnormal 
hyperpenetration to the deep choroid and sclera was observed as exemplified in Figure 4f. This 
hyperscattering could be explained by abnormality in the choroidal or RPE tissue, such as reduction of 
melanin content, abnormal thinning of the choroid or both. The hyposcattering appearance of choroidal 
vessels can be utilized as an indicator of the choroidal abnormality.  
Since the bidirectional mode is only sensitive to fast blood flow, it is selectively sensitive to the 
arteries among the choroidal vessels. This property of the bidirectional mode provides a similarity 
between bidirectional OCA and the early-phase (arterial phase) of ICGA as exemplified in Figure 1b and 
Figure 1e. For ICGA imaging of the PCV, feeder vessels were imaged at the early phase. It would be 
expected that the feeder vessels can be visualized by bidirectional OCA. In the current study, bidirectional 
OCA visualized choroidal vessels beneath or close to the PED in 3 of 5 PCV eyes to both graders. These 
choroidal vessels were correlated with the feeder vessels that appeared in early-phase ICGA. This 
indicates the utility of bidirectional OCA for noninvasive imaging of feeder vessels of PCV.  
The high-sensitive OCA of PCV cases visualized the three-dimensional (3-D) structure of the 
BVN and polypoids. It is known that a cluster of abnormal vessels are co-localized in some region 
beneath the PED and a feeder vessel connects the abnormal vessel cluster and a choroidal vessel7. 
The abnormal vessel cluster of PCV has been investigated by structural OCT with a 830-nm probe 
beam7, structural high-penetration OCT with a 1-μm probe beam13, and Doppler OCT with a 840-nm 
probe beam29. However, none of them has been used to visualize the comprehensive 3-D structure of PCV 
including the vessels cluster and the feeder vessel. As exemplified by Figure 7d, high-sensitive OCA has 
enabled comprehensive visualization of the 3-D structure of the PCV including the vessel cluster and the 
feeder vessel. This comprehensive investigative ability of high-sensitive OCA can provide a detailed 
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understanding of the pathology. 
The appearance of a high-sensitive Doppler en face projection image is generally well correlated 
with mid-phase ICGA, as exemplified in Figure 1c and 1f, Figure 2c and 2e, Figure 3a and 3b, Figure 3d 
and e, Figure 4c and 4e, Figure 5b and 5c, Figure 5f and 5g, and Figure 6c and 6f. The CNV appearance 
with high-sensitive OCA was also similar to that of ICGA. Furthermore, in some cases, such as shown in 
Figure 4, Figure 6, and Figure 7, high-sensitive OCA provided higher contrast than ICGA. 
In the current study, FA images showed leakages in some untreated cases including 1 eye with 
mCNV, 4 eyes with AMD and 1 eye with PCV. The number of leakages was 6 in total. In all leakage spots, 
a similar pattern was observed in en face high-sensitive OCA as exemplified in Figure 2b and 2e, Figure 
4b and 4e, Figure 5a and 5c, and Figure 7c and 7b. The leakage in FA is an indicator of abnormal 
penetration of a choroidal vessel into the retina, while the Doppler OCT, and hence OCA, is sensitive to 
localized motion and selectively contrasts the structure of the blood vessels. Although, the leakage is not 
directly detectable by OCA, its related structural abnormality can be detected. And hence, high-sensitive 
OCA has indirectly indicated the region of the leakage. Because of the difference in the contrast 
mechanism, OCA cannot be the full alternative for FA. However, the high correlation between OCA and 
FA and non-invasive nature of OCA would make OCA a comparable utility to FA.  
While FA and ICGA use fluorescent dye as a vessel contrast agent, HP-OCA uses blood flow as 
a contrast source. The different vessel contrast mechanism between conventional angiography and 
HP-OCA would result in different characteristics. FA and ICGA have advantages of time elapse imaging 
after dye injection and investigation of tissue damage through dye leakage. Conversely, OCA has the two 
major advantages of 3-D investigation and non-invasiveness. The 3-D visualization of the ocular 
vasculature would provide more detailed insight of the pathology. The non-invasiveness enables safe and 
repetitive application of OCA to the patient. This repetitive examination is particularly useful for the 
frequent monitoring of the outcome of treatments. This could provide insights in natural history and 
response to the treatment of retinal illness. In addition, OCA can be also utilized for mass-screening not 
only for the specific clinical diagnosis and the time-sequence monitoring. 
Since HP-OCA provides vast amount of information including a structural OCT volume and 
two types of Doppler OCT volumes, a conventional static-page-oriented patient report is not always 
convenient for clinicians. Alternatively, a sophisticated data browser is necessary. Figure 8 shows a screen 
shot of our custom made HP-OCA browser. It consists of an en face projection image of structural OCT 
and en face Doppler OCA in its left column, while cross-sectional images of structural OCT, Doppler 
tomogram, and the Doppler tomogram overlaid on the structural OCT are displayed at the right column. 
An operator is allowed to quickly find the point of pathology in the en face images. By pointing the 
position of pathology in the en face images with a line cursor, corresponding cross-sections are displayed 
in the right column. Hence the operator can utilize both the structural OCT projection and en face OCA to 
quickly find the pathologic region. This simultaneous usage of the structural projection and en face OCA 
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reduces the risk of overlooking of pathologies in comparison to a conventional OCT. The operator is also 
allowed to markup one of the cross-sectional images. As marking up an image, the same mark 
simultaneously appears at the same location in the other cross-sectional images. This function enables 
quick co-registration of structural and Doppler findings. By using a well-designed data browser, such as 
this HP-OCA browser, the operator can quickly and effectively review the huge amount of information 
provided by HP-OCA. 
 
 
Figure 8. A screen shot of a custom-made HP-OCA data browser. The en face projection of 
structural OCT and en face Doppler OCA are displayed at the left column and the 
cross-sectional structural OCT, Doppler tomogram, and the Doppler tomogram overlaid on 
the structural OCT are displayed in the right column. As pointing the position of interest in 
the en face images by a red line cursor, the corresponding cross-sectional images are 
simultaneously displayed in the right column. The operator can mark up one of the 
cross-sections, and the same mark simultaneously appears at the same positions of the other 
cross-sections. 
 
 
 In this paper, we demonstrated vasculature imaging of exudative macular diseases by 
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HP-OCA. HP-OCA provided two measurement modes; i.e. bidirectional OCA and high-sensitive OCA. 
With bi-directional OCA, feeder vessels of the PCV were successfully visualized. Conversely, the 
high-sensitive OCA provided similar angiograms to the mid-phase of ICGA but with higher contrast. This 
new modality can be partially utilized as an alternative to FA and ICGA. In addition, the non-invasive and 
3-D imaging ability of OCA enables wider applications than FA and ICGA. 
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Supplementary material 
Modified Phase-II numerical phase stabilization 
In this study, we employed a custom-made HP-OCA system. Most of the details have been described in 
Ref. 32, except for an updated algorithm for Doppler tomography reconstruction. HP-OCA relies on 
software based phase stabilization algorithms, called phase-1 and phase-2 phase stabilizations. The 
phase-1 stabilization cancels the phase error of OCT that occurred because of system instability. The 
phase-2 stabilization is for fine cancelation of system-induced phase error and also for cancelation of the 
offset Doppler shift that occurred with bulk motion of the eye. The HP-OCA system employed in this 
study uses an updated version of the phase-2 stabilization algorithm. 
The details of the original version of the phase-2 stabilization algorithm is described in Section 2.3 
of Ref. 32. The core process of this algorithm is iterative weighted regression of the measured 
depth-resolved Doppler shift signal. In the original algorithm, the weight was updated according to the 
following equations for each iteration (Eqs. (11) and (12) of Ref. 34). 
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where Mm ,,1,0   is the index of iteration with M of the maximum iteration index,  mW  is 
fitting weight of m-th iteration with   as the Fourier pair of wavenumber.  I  is signal intensity of 
OCT, 2  is the noise level of the OCT.    is the measured Doppler phase signal corrected by 
phase-1 stabilization algorithm and 11   mm ba   is a linear fitting of the phase at (m-1)-th iteration. 
In the updated algorithm, the Eq. (2) was revised to be 
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where p  is a constant determined by the phase stability obtained after the phase-1 phase stabilization. 
Note that Eq. (4) is a monotonically decreasing sigmoid function with the maximum limit of  and the 
minimum limit of p , and we set p to make p to be the phase noise level. In our particular case, 
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12p . M  is the total iteration number of iteration, and in our particular case, 7M . Note that Eq. 
(4) is a sigmoid function. And hence, In this condition,  MpmT ,;  keeps large for the first iterations, 
rapidly decreases at around the middle of the iteration, and becomes relatively constant for the late steps 
of the iterations. Hence this algorithm estimates the phase error caused by the system instability and the 
bulk eye motion more accurately than our previous algorithm, and improves the image quality of Doppler 
tomography and OCA. 
After applying the phase-2 stabilization, we applied a 3-D Kasai auto-correlation filter33,34 to the 
Doppler signal to further improve the Doppler sensitivity as described in Section 2.3 of Ref. 32. In this 
particular study, we have further optimized the kernel size of this filter in comparison to that of Ref. 32. 
The kernel sizes utilized in this study were 4 pixels (depth) × 4 pixels (horizontal) × 1 pixel (vertical) for 
the bi-directional scanning mode, and 4 pixels (depth) × 1 pixel (horizontal) × 4 pixels (vertical) for the 
high-sensitive scanning mode. This kernel sizes correspond to the physical size 19.0 μm (depth) × 38.8 
μm (horizontal) × 30.0 μm (vertical) for the bi-directional mode and 19.0μm (depth) × 30.0 μm 
(horizontal) × 38.8 μm (vertical) for the high-sensitive mode. 
